Navigation Links
Watson to Present at the 30th Annual J.P. Morgan Healthcare Conference
Date:12/28/2011

PARSIPPANY, N.J., Dec. 28, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's President and Chief Executive Officer, will provide an overview and update of the Company's business at the 30th Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2012 at 7:30 am Pacific Standard Time (10:30 am Eastern Standard Time) at the Westin St. Francis in San Francisco, California. The presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at http://ir.watson.com.  The webcast can also be accessed at the following URL:

http://jpmorgan.metameetings.com/webcasts/healthcare12/directlink?ticker=WPI

An archived version will be available by the end of the day of the live presentation and can be accessed at the same locations for 90 days.

About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

 CONTACTS: Investors: 

Patty Eisenhaur 

(862) 261-8141 

  Media: 

Charlie Mayr 

(862) 261-8030(Logo: http://photos.prn
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Watson to Present at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top
2. Watson Launches Generic LoSEASONIQUE(R)
3. Watson Launches Generic LIPITOR®
4. Watson to Present at the 2011 Piper Jaffray Health Care Conference
5. Watson Wins Kentucky Drug Pricing Litigation
6. Watson Confirms Exelon(R) Patent Challenge
7. Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA
8. Watson Third Quarter 2011 Net Revenue Climbs 23% to $1.1 Billion; Non-GAAP Diluted EPS of $1.09; GAAP Diluted EPS of $0.54
9. Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX®
10. Watson to Present at the 2011 Annual Credit Suisse Health Care Conference
11. Watson Confirms Daytrana(R) Patent Challenge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... WASHINGTON and NEW YORK ... 2014 As the leading distributor of market ... a new research report by IQ4I Research and Consultancy ... To learn more about IQ4I Research visit: ... Active Pharmaceutical Ingredients Global Market – Forecast ...
(Date:11/26/2014)... 25, 2014 Reinforcing its commitment to enabling ... PHG AEX: PHIA) today announced 510(k) ... for its IQon Spectral CT , presenting an ... technology adds a new dimension to Computed Tomography (CT) ... characterize structures based on their material content within a ...
(Date:11/26/2014)... Pa. , Nov. 25, 2014  Unilife Corporation ... of injectable drug delivery systems, today announced that its ... to present at the Piper Jaffray 26th Annual Healthcare ... a.m. EST on Tuesday, December 2, 2014. ... Internet as a "live" listen only Webcast. To listen, ...
Breaking Medicine Technology:MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3Philips receives FDA 510(k) clearance for IQon Spectral CT 2Philips receives FDA 510(k) clearance for IQon Spectral CT 3Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2
(Date:11/27/2014)... Vancouver, BC (PRWEB) November 27, 2014 ... http://www.idataresearch.com ), those companies looking to break into the ... in other medical specialties, other than the MIS field ... almost one-third of the U.S. surgical robotics market by ... nearing saturation,” explains Dr. Kamran Zamanian, CEO and President ...
(Date:11/27/2014)... PITTSBURGH, PA (PRWEB) November 27, 2014 ... suffer from an embarrassing fact of life, and she ... musty a few minutes later, I decided that there ... longer periods," she said. , Easy to use and ... maintains freshness in a woman’s private areas throughout the ...
(Date:11/27/2014)... Dennis Thompson HealthDay Reporter ... experimental Ebola vaccine appears to be safe and produces an ... virus, according to early clinical trial results reported by the ... phase I clinical trial for the vaccine paves the way ... Liberia and Sierra Leone as early as January, said Dr. ...
(Date:11/27/2014)... Now that Thanksgiving is finally here and ... Emassagechair.com has announced its eagerly awaited, once yearly ... Negotiating on behalf of their customers, and drawing on ... has generated significant buzz in the industry with the ... , Shoppers are excited for significant savings available on ...
(Date:11/27/2014)... 2014 “LAB.C” was featured on NewsWatch as ... and coolest technology products available to consumers. Mallory Sofastaii, a ... review and shared with viewers the company offers a ... devices. , Consumers love portability and functionality. A unique ... for the iPhone5 and 5S has a portable USB charger ...
Breaking Medicine News(10 mins):Health News:U.S. Robotic Surgery Market Set to Diversify and Grow: Intuitive Surgical’s ‘da Vinci’ Robot Revenues to Increasingly Rely On Procedures and Services 2Health News:Early Trial Promising for Ebola Vaccine 2Health News:Early Trial Promising for Ebola Vaccine 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 4Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2
... to restart production of missing protein , TUESDAY, Aug. ... muscle appears to jump-start the production of a crucial ... British researchers report. , The treatment so far is ... the debilitating and ultimately fatal disease, but scientists are ...
... , , , ... over $800,000 on prescription drugs through Iowa Drug Card since the launch ... free discount drug cards to Iowa residents, was launched in June, 2008. ... program. , , Former Hawkeye,s Head Football Coach ...
... TSX: COM, , , VANCOUVER, Aug. 25 ... ("Cardiome" or the "Company") announced today that its Board of ... to purchase for cancellation up to 6,470,588 of its common ... million. The offer will be conducted as a modified "Dutch ...
... , IRVINE, Calif., Aug. 25 CorVel Corporation ... Board of Directors has approved a 1,000,000 share expansion to its ... for repurchase over the life of the program to 14,150,000 shares. ... program in the fall of 1996. From the program,s inception through ...
... , CHARLES TOWN, W.Va., Aug. 25 ReBuilder ... treatments for the pain resulting from Peripheral Neuropathy and Peripheral ... and is now reporting profits for the first Quarter of ... ) , , "Our efforts to ...
... , , CENTER CITY, ... helps people reclaim their lives from addiction, has appointed William ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20061128/CGTU038LOGO ) , (Photo: ... to announce the appointment of William C. Moyers as Vice ...
Cached Medicine News:Health News:Experimental Treatment Could Fight Muscular Dystrophy 2Health News:Iowa Drug Card a Huge Success With Iowans 2Health News:Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common Shares 2Health News:Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common Shares 3Health News:Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common Shares 4Health News:Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common Shares 5Health News:Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common Shares 6Health News:CorVel Announces Expansion to Share Buyback Program 2Health News:CorVel Announces Expansion to Share Buyback Program 3Health News:ReBuilder Medical Technologies, Inc. Announces First Quarter 2009 is Profitable 2Health News:William C. Moyers Appointed Vice President of Foundation Relations for Hazelden 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: